MERCK Kommanditgesellschaft auf Aktien

MERCK Kommanditgesellschaft auf Aktien (DE) has reported its carbon emissions for the most recent available years, demonstrating a commitment to climate action within the Pharmaceutical Preparation Manufacturing industry.

For 2025, the company reported a total of approximately 4.75 billion kg CO2e. This figure comprises Scope 1 emissions of approximately 658 million kg CO2e, Scope 2 emissions of approximately 197 million kg CO2e (market-based), and Scope 3 emissions totalling approximately 3.90 billion kg CO2e. The largest contributors to Scope 3 emissions were purchased goods and services (approximately 2.05 billion kg CO2e) and the use of sold products (approximately 928 million kg CO2e).

In 2024, total emissions were approximately 5.57 billion kg CO2e. This included Scope 1 emissions of approximately 858 million kg CO2e, Scope 2 emissions of approximately 227 million kg CO2e (market-based), and Scope 3 emissions of approximately 4.48 billion kg CO2e. Purchased goods and services represented the most significant portion of Scope 3 emissions, at approximately 2.47 billion kg CO2e.

MERCK Kommanditgesellschaft auf Aktien has set ambitious climate targets. The company is committed to reducing its direct (Scope 1) and indirect (Scope 2) greenhouse gas emissions by 50% by 2030, using 2020 as a baseline year. Furthermore, it aims to reduce its Scope 3 emissions across the entire value chain by 52% per euro of value added by 2030. The company has also pledged to achieve climate-neutral operations along its entire value chain by 2040, aligning with the Paris Agreement's goal of reaching net-zero emissions by 2050. These targets have been validated by the Science Based Targets initiative (SBTi).

The company's emissions data is inherited from its parent organisation, Merck KGaA, which is at cascade level 0.